Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010–2015
2016; Oxford University Press; Volume: 64; Issue: 3 Linguagem: Inglês
10.1093/cid/ciw745
ISSN1537-6591
AutoresGrace D. Appiah, Sandra S. Chaves, Pam Daily Kirley, Lisa A. Miller, James Meek, Evan J. Anderson, Oluwakemi Oni, Patricia Ryan, Seth Eckel, Ruth Lynfield, Marisa Bargsten, Shelley M. Zansky, Nancy M. Bennett, Krista Lung, Christie McDonald-Hamm, Ann Thomas, Diane Brady, Mary Lou Lindegren, William Schaffner, Mary Hill, Shikha Garg, Alicia M. Fry, Angela P. Campbell,
Tópico(s)COVID-19 epidemiological studies
Resumo(See the Editorial Commentary by Martin on pages 368-9.)Using population-based surveillance data, we analyzed antiviral treatment among hospitalized patients with laboratory-confirmed influenza. Treatment increased after the influenza A(H1N1) 2009 pandemic from 72% in 2010-2011 to 89% in 2014-2015 (P < .001). Overall, treatment was higher in adults (86%) than in children (72%); only 56% of cases received antivirals on the day of admission.
Referência(s)